Today · Thirsty Thursday → Members get deals first → Order ahead, skip the line →
Open daily9am – 9pm 843 Howard St · SoMa Directions → (510) 982-1460

Cannabis and opioids for pain: what the research shows

Chronic pain, opioid use and overdose data: what studies found and where they disagree

Why people ask about cannabis and opioids

The opioid overdose crisis has pushed a lot of people living with long-term pain, and the people who care about them, to take a hard look at their options. Cannabis comes up often. It is a fair question, and the honest answer is more complicated than either side of the debate tends to admit. Here is what the research does and does not show so far.

What research shows about cannabis and chronic pain

In 2017 the National Academies of Sciences, Engineering, and Medicine (NASEM) published a major review of the research on cannabis and health. The committee concluded that there is conclusive or substantial evidence that cannabis is effective for the treatment of chronic pain in adults. Chronic pain was one of only a few health uses where the report reached that level of confidence.

The size of the benefit is a separate question. The National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health, describes the evidence as suggesting modest benefits for chronic pain. It summarizes a 2018 review of 47 studies with 4,743 participants: 29 percent of people taking cannabis or cannabinoids had their pain drop by 30 percent, compared with 26 percent of people taking a placebo. People taking cannabis-based medicines were also more likely to drop out of studies because of side effects.

In 2021 the International Association for the Study of Pain (IASP), a leading professional group for pain researchers and clinicians, decided not to endorse the general use of cannabinoids to treat pain. It said the clinical evidence on effectiveness and safety is not yet strong enough, and called for more high-quality research.

Can cannabis help people use fewer opioids?

This is where the evidence is genuinely mixed.

Early state-level studies looked promising

A widely cited 2014 study in JAMA Internal Medicine found that from 1999 to 2010, states with medical cannabis laws had opioid painkiller overdose death rates about 25 percent lower, on average, than states without those laws. The authors were careful to call this an association, not proof that the laws caused the difference. Even so, the finding was often repeated as evidence that cannabis access saves lives.

A longer look reversed the result

In 2019, a team of researchers re-ran the same analysis with data through 2017 and published it in PNAS. The original result held for the earlier years, but over the longer period it flipped: states with medical cannabis laws now showed overdose death rates about 23 percent higher. The authors did not conclude that cannabis laws increase overdose deaths. Their view was that both results are most likely coincidental, because state-level data cannot show what individual people actually do, and many other factors drive overdose trends. They urged skepticism toward claims that medical cannabis laws reduce opioid overdose deaths.

Studies that follow individual patients

Following real patients over time gives a closer view. An Australian study published in The Lancet Public Health tracked people with chronic non-cancer pain who were prescribed opioids for four years. According to the research team at UNSW Sydney, there was no clear evidence that cannabis use reduced pain severity, reduced how much pain interfered with daily life, or led people to lower their opioid use or dose. NCCIH also notes that a 2017 review of studies giving cannabinoids alongside opioids found inconsistent results, and none of the high-quality studies showed that cannabinoids led to less opioid use.

Risks worth knowing

  • Cannabis use disorder is real. The CDC estimates that about 3 in 10 people who use cannabis have cannabis use disorder. Starting young and using more often both raise the risk.
  • Side effects are common enough to matter. In pain studies, people taking cannabis-based medicines were more likely than those on placebo to stop because of side effects.
  • Drug interactions. NCCIH notes that CBD can interact with other medicines, which is one more reason your prescriber should know everything you take.
  • Driving. NASEM found substantial evidence linking cannabis use to a higher risk of motor vehicle crashes.
  • Smoking. NASEM also found substantial evidence that long-term cannabis smoking is linked to worse respiratory symptoms and more frequent bronchitis episodes.

Never stop or change opioids on your own

If you take prescribed opioids, do not stop, cut back, or swap them for cannabis without talking to the clinician who prescribes them. Stopping suddenly can bring on withdrawal and a return of severe pain. Any change to an opioid dose should be planned with your prescriber.

Talk to your doctor

If you are curious whether cannabis has any place in your pain care, bring it up with your doctor or pharmacist. Be open about what you use, how much, and how often, including CBD, so they can check for interactions and help you weigh the possible benefits against the risks. Dispensary staff can explain products and labels, but they cannot give medical advice or adjust your treatment.

The bottom line

Research suggests cannabis may offer modest relief for some adults with chronic pain. The evidence that it helps people cut back on opioids is limited and inconsistent, and the early state-level studies suggesting fewer overdose deaths did not hold up over time. Cannabis is not a proven replacement for opioid treatment, and it carries its own risks.

This article is general information, not medical advice.

Sources

  1. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (Summary). National Academies of Sciences, Engineering, and Medicine, National Academies Press, 2017.
  2. Cannabis (Marijuana) and Cannabinoids: What You Need To Know. National Center for Complementary and Integrative Health, National Institutes of Health, last updated 2019.
  3. IASP Position Statement on the Use of Cannabinoids to Treat Pain. International Association for the Study of Pain, 2021.
  4. Bachhuber MA, et al. Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010. JAMA Internal Medicine, 2014.
  5. Shover CL, Davis CS, Gordon SC, Humphreys K. Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences (PNAS), 2019.
  6. UNSW study finds no strong evidence that cannabis reduces chronic pain (on Campbell G, et al., The Lancet Public Health, 2018). UNSW Sydney, 2018.
  7. Cannabis Use Disorder. Centers for Disease Control and Prevention.
Written by Michael Nolin

Michael Nolin writes The Green Door's guides on how cannabis affects the body, with the research behind them.

More from Michael Nolin →